All News
Industry Press Releases from EULAR19
Many of the great presentations from EULAR 2019 feature industry sponsored clinical trials. Often these become the pivotal studies for regulatory approval and the annual congresses are their first look.
Read Article
Immune mediated reactions from checkpoint inhibitors mostly are rheumatologic. THU0628 #EULAR2019 @RheumNow
Janet Pope Janetbirdope ( View Tweet)
Come see our poster THU0689- asthma and elevation of ACPA prior to RA onset. Women with asthma had 4-fold increased risk pre-RA ACPA+ a mean of 8 years prior to RA dx. Supports mucosal hypothesis where inflamed airways promote ACPA genesis #EULAR19 https://t.co/zivVinwEWS
Jeff Sparks jeffsparks ( View Tweet)
Giant cell arteritis 42% with clinical remission and no treatment after 1 year of weekly #Tocilizumab... remission after 2 years.. Dr. John H. Stone https://t.co/WqvGLxBLQA
Dr.Martínez MtzReuma ( View Tweet)
ANCA #VASCULITIS
👉🏻A maintenance treatment should be prescribed
👉🏻Anti-PR3 patients > MPO
👉🏻Rituximab is the best drug to maintain remission
👉🏻Some patients could deserve a"very long term maintenance treatment",may be all life
👉🏻A specific approach is needed in EGPA
#EULAR2019 https://t.co/s3JlUahN4m
Juan Ovalles, MD, PhD DrJuanOvalles ( View Tweet)
Flares: well, I had hoped for more from that top highlighted line. What is going to happen to our real-life patients who have had a year of TCZ and then come off? https://t.co/QvsEfYpahi
David Liew drdavidliew ( View Tweet)
From there, we’re looking at clinical clinician choice. So what happened when TCZ stopped? https://t.co/HJl0VJuN8p
David Liew drdavidliew ( View Tweet)
Riociquat studied in early PSS w/ mRSS 10–22 and showed a trend to decrease mRSS (p=0.08) & no effect on lungs. But subanalysis of SSc-ILD showed significant improvements in FVC. #EULAR19 OP0183 https://t.co/fP6snUHU1r
Dr. John Cush RheumNow ( View Tweet)
#EULAR2019 ⬇️IgG o nl preRTX y ⬇️IgG postRTX ⬆️⬆️⬆️riesgo de infección (RR >15)
Debe de ser mandatorio vigilar Igs en pacientes bajo tx con rituximab @PanlarLeague @eular_org https://t.co/we6G1D4VXu
𝐽𝑎𝑣𝑖𝑒𝑟 𝑀𝑒𝑟𝑎𝑦𝑜-𝐶ℎ𝑎𝑙𝑖𝑐𝑜 MerayoDr ( View Tweet)
Welcome to the second day of the #EULAR2019 Joint Congress with PReS. Check the scientific programme and highlights for your day’s itinerary. https://t.co/KiNEJUcHJI https://t.co/MFt21kDMJs
Links:
EULAR | The European League Against Rheumatism eular_org ( View Tweet)
Osteoporosis Medication. When to stop? When to switch?
I find this hard so here are Swiss guidelines #eular2019 https://t.co/WNhDanIXRg
Dr Irwin Lim _connectedcare ( View Tweet)
You speak sense. And I do what you do for steroid-induced osteoporosis prevention. However the convenience of Denosumab is winning at least in Australia. Think Around 80% of market #EULAR2019 https://t.co/nL3BzCon8g
Dr Irwin Lim _connectedcare ( View Tweet)
You can taper prednisone for pts doing well on combination or monoRx with Tocilizumab in RA who achieved low disease activity or remission but with slightly more flares in RCT of steroid taper va not. Abstract OP0030 #EULAR2019 @RheumNow https://t.co/Mb1OVtnJ1R
Janet Pope Janetbirdope ( View Tweet)
EULAR Madrid is off to a great start. Madrid is not too hot compared to two years ago. Beautiful region to explore. Do you know where this castle from 12th c that inspired Disney castle is? @RheumNow #EULAR2019 https://t.co/N2znTe3EFW
Janet Pope Janetbirdope ( View Tweet)
Reunite with old friends and extend your professional network at the #EULAR2019 Networking Platform in Hall 6. We hope you are enjoying your evening! https://t.co/zcqx9wHSmU
EULAR | The European League Against Rheumatism eular_org ( View Tweet)
https://t.co/Cw2wi8Jj0D
Dr. Dinesh Khanna sclerodermaUM ( View Tweet)
impact on mRSS in abatacept group whereas placebo did change (purple lines). Time for personalized medicine!! #EULAR2019 https://t.co/XmYLq8ddIp
Dr. Dinesh Khanna sclerodermaUM ( View Tweet)
Early SSC is very hetogeneous disease. Data from the ASSET trial @bmsnews @UMIntMed and Whitfield lab (funded by @NIAIDNews) shows 1. Skin gene expression can largely be divided into 3 large groups with 41% with Normal like expression!! 2. Patients RX with abatacept had striking
Dr. Dinesh Khanna sclerodermaUM ( View Tweet)